BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Warnecke T, Schäfer KH, Claus I, Del Tredici K, Jost WH. Gastrointestinal involvement in Parkinson's disease: pathophysiology, diagnosis, and management. NPJ Parkinsons Dis 2022;8:31. [PMID: 35332158 DOI: 10.1038/s41531-022-00295-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Jellinger KA. The pathobiological basis of depression in Parkinson disease: challenges and outlooks. J Neural Transm (Vienna) 2022. [PMID: 36322206 DOI: 10.1007/s00702-022-02559-5] [Reference Citation Analysis]
2 Chen SJ, Lin CH. Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis. J Biomed Sci 2022;29:54. [PMID: 35897024 DOI: 10.1186/s12929-022-00839-6] [Reference Citation Analysis]
3 Minakawa EN. Bidirectional Relationship Between Sleep Disturbances and Parkinson's Disease. Front Neurol 2022;13:927994. [DOI: 10.3389/fneur.2022.927994] [Reference Citation Analysis]
4 Zhu M, Liu X, Ye Y, Yan X, Cheng Y, Zhao L, Chen F, Ling Z. Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease. Front Immunol 2022;13:937555. [DOI: 10.3389/fimmu.2022.937555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Xu J, Wang L, Chen X, Le W. New Understanding on the Pathophysiology and Treatment of Constipation in Parkinson’s Disease. Front Aging Neurosci 2022;14:917499. [DOI: 10.3389/fnagi.2022.917499] [Reference Citation Analysis]
6 Pilipovich A, Vorob’eva O. Upper gastrointestinal tract dysfunction and its correction by dopamine agonists for patients with Parkinson’s disease of I—III stage. Z nevrol psikhiatr im S S Korsakova 2022;122:86. [DOI: 10.17116/jnevro202212211186] [Reference Citation Analysis]